Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.685 USD | -2.40% | -11.77% | +79.50% |
05-07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
05-01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+79.50% | 3.29B | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.55% | 21.25B | |
-5.38% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- SMMT Stock
- News Summit Therapeutics Inc.
- Summit Therapeutics : HC Wainwright Downgrades Summit Therapeutics to Neutral from Buy